Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coupling proteomics and transcriptomics in the quest of subtype‐specific proteins in breast cancer

5 Feb 2013

Abstract excerpt

Breast-cancer subtypes present with distinct clinical characteristics. Therefore, characterization of subtype-specific proteins may augment the development of targeted therapies and prognostic biomarkers. To address this issue, MS-based secretome analysis of eight breast cancer cell lines, corresponding to the three main breast cancer subtypes was performed. More than 5200 non-redundant proteins were identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Clusterin in disease pathology
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23386393
DOI: 10.1002/pmic.201200526

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coupling proteomics and transcriptomics in the quest of subtype‐specific proteins in breast cancerPMID 23386393Read ↗

High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratificationSemantic proximity Read ↗

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancerSemantic proximity Read ↗

Breast cancer classification based on proteotypes obtained by SWATH mass spectrometrySemantic proximity Read ↗

Data Descriptor: Proteomic profiling across breast cancer cell lines and modelsSemantic proximity Read ↗

Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancerSemantic proximity Read ↗

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniquesSemantic proximity Read ↗

The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity Read ↗

Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics AnalysisSemantic proximity Read ↗

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkersSemantic proximity Read ↗

Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imagingSemantic proximity Read ↗

Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survivalSemantic proximity Read ↗

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.